Global Amebocyte Lysate Market Professional Survey Report 2020 By Innovation Market Research, Inc

 Pulichser: XYZResearch

December 2020

 Pages: 108

 IMR 4074

In this report,global Amebocyte Lysate Market will reach 507.81 Million USD by the end of 2022 with a CAGR of 9.96%. The global Amebocyte Lysate market is valued at 315.94 Million USD in 2017 and will reach 507.81 Million USD by the end of 2022, growing at a CAGR of 9.96% during 2017-2022.

Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram-negative bacteria. This reaction is the basis of the Amebocyte Lysate test, which is then used for the detection and quantification of bacterial endotoxins.

Amebocyte Lysate can be divided into two categories—Limulus Amebocyte Lysate type and Tachypleus Amebocyte Lysate type. Limulus Amebocyte Lysate type production market share accounted for the highest proportion, with a figure of 75.74% in 2017, Tachypleus Amebocyte Lysate type account for 24.26%.

The consumption market share of global Amebocyte Lysate in Drug Testing use, Clinical Diagnosis use and other applications have been stable year by year, at 52.16%, 33.90% and 13.94% respectively in 2017, and for several consecutive years, the amplitude was within 2 percent. This indicates that the segment of the Amebocyte Lysate in the global market tends to be fixed without great changes. Among them, the Amebocyte Lysate market has the most promising sales prospects in Drug Testing use.

Innovation Market Research, Inc center data shows that Europe is the biggest contributor to the Amebocyte Lysate revenue market, accounted for 57.90% of the total global market with a revenue of 182.93 million USD in 2017, followed by United States, 30.71% with a revenue of 97.04 million USD. LONZA is the largest company in the global Amebocyte Lysate market, accounted for 64.02% of the revenue market share in 2017, followed by Charles River Laboratories and Associates of Cape Cod, accounted for 20.08% and 5.59% of the revenue market share in 2017. Market competition is not intense. The top three manufacturers account for 89.69% of the revenue market.

Geographically, global Amebocyte Lysate market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Charles River Laboratories
Associates of Cape Cod
Zhanjiang A&C Biological
Zhanjiang Bokang
Fuzhou Xinbei

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Limulus Amebocyte Lysate
Tachypleus Amebocyte Lysate

For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Amebocyte Lysate for each application, including

Production, consumption, revenue, market share and growth rate are the key targets for Amebocyte Lysate from 2014 to 2026 (forecast) in these regions
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!

  +91 810 895 3541